Vitiligo. What is new?;Vitiligo: Was ist neu?

Hautarzt

Volumn 61, Issue 7, 2010, Pages 578-585

  Schallreuter, K U ^a   Salem, M M A E L ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

DNA damage; Oxidative stress; p53; Repigmentation; Vitiligo

Indexed keywords

HYDROGEN PEROXIDE; PROTEIN P53; TP53 PROTEIN, HUMAN;

ARTICLE; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; SKIN; VITILIGO;

HUMANS; HYDROGEN PEROXIDE; MODELS, IMMUNOLOGICAL; SKIN; TUMOR SUPPRESSOR PROTEIN P53; VITILIGO;

EID: 79251514766     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-009-1916-9     Document Type: Article

References (40)

1. Boersma BR, Westerhof W, Bos JD (1995) Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. J Am Acad Dermatol 33:990-995
2. Buckley DA, Rogers S (1996) Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 21:43-45 (Pubitemid 26167419)
3. Chiaverini C, Passeron T, Ortonne JP (2002) Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol 16:137-138 (Pubitemid 34460713)
4. Calanchini-Postizzi E, Frenk E (1987) Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin. Dermatologica 174:266-271 (Pubitemid 17075438)
5. Casp CB, She JX, McCormack WT (2002) Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 15:62-66 (Pubitemid 34535975)
6. Dell'Anna ML, Picardo M (2006) A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo Pigment Cell Res 19:406-411 (Pubitemid 44326402)
7. Even-Paz Z (1996) Dermatology at the Dead Sea Spas. Isr J Med Sci 32(Suppl):11-15
8. Gauthier Y, Cario-Andre M, Taieb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16:322-332 (Pubitemid 36950564)
9. Grimes PE, Elkadi T, Sanders J (1999) Epstein-Barr virus infection in patients with vitiligo (abstr). J Invest Dermatol 112:604
10. Grimes PE, Soriano T, Dytoc MT (2002) Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 47:789-791 (Pubitemid 35239348)
11. Howitz J, Brodthagen H, Schwartz M, Thomsen K (1977) Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 113:47-52 (Pubitemid 8020128)
12. Jin Y, Mailloux CM, Gowan K et al (2007) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356(12):1216-1225 (Pubitemid 46465597)
13. Kemp EH, Gavalas NG, Gawkrodger DJ, Weetman AP (2007) Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo. Autoimmun Rev 6(3):138-142 (Pubitemid 46187335)
14. Krüger C, Smythe JW, Spencer JD et al (2010) Combined climatotherapy at the Dead Sea significantly improves quality of life and supports coping with the disease in patients with vitiligo. Acta Derm Venereol (submitted)
15. Kushelevsky AP, Slitkin MA (1975) Ultraviolet measurements at the Dead Sea and Beersheba. Isr J Med Sci 11:488-490
16. Neumeister P, Strunk D, Apfelbeck U et al (2000) Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. Lancet 355(9212):1334-1350
17. Njoo MD, Spuls P, Bos JD et al (1998) Nonsurgical repigmentation therapies in vitiligo - meta-analysis of the literature. Arch Dermatol 134:1532-1540 (Pubitemid 29009253)
18. Oyarbide-Valencia K, Boorn JG van den, Denman CJ et al (2006) Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev 5(7):486-492
19. Papadopoulos L, Bor R, Legg C, Hawk JL (1998) Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in a etiology. Clin Exp Dermatol 23:243-248 (Pubitemid 29166502)
20. Papadopoulos L, Bor R, Legg C (1999) Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 72(Pt3):385-396 (Pubitemid 29465543)
21. 2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J 23(11):3790-3807
22. Salzer BA, Schallreuter KU (1995) Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology 190:109-115
23. Schallreuter KU (1999) Verdammte weiße Flecken. University of Bradford, Bradford, UK
24. Schallreuter KU (1995) Beta adrenergic blocking agents can provoke vitiligo. Br J Dermatol 132(1):168-169
25. Schallreuter KU, Chiuchiarelli G, Cemeli E et al (2006) Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo J Invest Dermatol 126:1036-1042
26. Schallreuter KU, Bahadoran P, Picardo M et al (2008) Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 17:139-140
27. Schallreuter KU, Krüger C, Würfel BA et al (2008b) From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol 47(7):743-753 (Pubitemid 352016092)
28. Schallreuter KU, Lemke R, Brandt O et al (1994) Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 188:269-275 (Pubitemid 24105481)
29. Schallreuter KU, Levenig C, Berger J (1991) Vitiligo and cutaneous melanoma. A case study. Dermatologica 183:239-245
30. Schallreuter KU, Moore J, Behrens-Williams S et al (2002) Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 41:482-487 (Pubitemid 35021486)
31. Schallreuter KU, Rokos H (2007) From the bench to the bedside: Proton pump inhibitors can worsen vitiligo. Br J Dermatol 156:1362-1402
32. Schallreuter KU, Tobin DJ, Panske (2002) A decreased photo damage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo. Dermatology 204:194-201 (Pubitemid 34628308)
33. Schallreuter KU, Wood JM, Pittelkow MR et al (1994) Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263:1444-1446 (Pubitemid 24137834)
34. Schallreuter KU, Zschiesche M, Moore J et al (1998) In vivo evidence for compromised phenylalanine metabolism in vitiligo. Biochem Biophys Res Commun 243:395-399 (Pubitemid 28414036)
35. Spritz R, Fain P, Bennett D (2003) The epidemiology and genetics of generalized vitiligo. Pigment Cell Res 16:589-590
36. Spritz RA, Gowan K, Bennett DC, Fain PR (2004) Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 74:188-191 (Pubitemid 38085251)
37. Tosti A, Bardazzi F, De Padova MP et al (1986) Deafness and vitiligo in an Italian family. Dermatologica 172:178-179
38. Wagoner MD, Albert DM, Lerner AB et al (1983) New observations on vitiligo and ocular disease. Am J Ophthalmol 96:16-26 (Pubitemid 13073317)
39. Westerhof W, Nieuweboer-Krobotova L (1997) Treatment of vitiligo with UVB radiation vs topical psoralen plus UVA. Arch Dermatol 133:1525-1528
40. Wood JM, Gibbons NC, Chavan B, Schallreuter KU (2008) Computer simulation of heterogeneous single nucleotide polymorphisms in the catalase gene indicates structural changes in the enzyme active site, NADPH-binding and tetramerization domains: a genetic predisposition for an altered catalase in patients with vitiligo? Exp Dermatol 17(4):366-371 (Pubitemid 351338682)